Eli Lilly (LLY) Says Primary Endpoints Not Met in Two Solanezumab EXPEDITION Phase IIIs

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/21/2026

1. ROST
2. WMT
3. AAP
4. HD
5. SFNC
6. FMG:AU
7. AVAH
8. JHX
9. FSUGY
10. ANF

Go back to Eli Lilly (LLY) Says Primary Endpoints Not Met in Two Solanezumab EXPEDITION Phase IIIs
Lilly (Eli) & Co. (NYSE: LLY) Delayed: 1244.40 --0 (-0%)
Previous Close $1244.40    52 Week High $88.16 
Open $1244.40    52 Week Low $67.88 
Day High $1244.40    P/E 288.06 
Day Low $1244.40    EPS $4.32 
Volume 3,946